Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
Add more filters










Publication year range
1.
Nat Commun ; 7: 11578, 2016 05 13.
Article in English | MEDLINE | ID: mdl-27174498

ABSTRACT

The prolactin receptor is an archetype member of the class I cytokine receptor family, comprising receptors with fundamental functions in biology as well as key drug targets. Structurally, each of these receptors represent an intriguing diversity, providing an exceptionally challenging target for structural biology. Here, we access the molecular architecture of the monomeric human prolactin receptor by combining experimental and computational efforts. We solve the NMR structure of its transmembrane domain in micelles and collect structural data on overlapping fragments of the receptor with small-angle X-ray scattering, native mass spectrometry and NMR spectroscopy. Along with previously published data, these are integrated by molecular modelling to generate a full receptor structure. The result provides the first full view of a class I cytokine receptor, exemplifying the architecture of more than 40 different receptor chains, and reveals that the extracellular domain is merely the tip of a molecular iceberg.


Subject(s)
Crystallography, X-Ray/methods , Models, Molecular , Receptors, Prolactin/chemistry , Humans , Magnetic Resonance Spectroscopy/methods , Micelles , Protein Conformation, alpha-Helical , Protein Domains , Receptors, Prolactin/isolation & purification , Scattering, Small Angle
2.
Biochemistry ; 43(43): 13755-65, 2004 Nov 02.
Article in English | MEDLINE | ID: mdl-15504038

ABSTRACT

Prolactin, a lactogenic hormone, binds to two prolactin receptors sequentially, the first receptor binding at site 1 of the hormone followed by the second receptor binding at site 2. We have investigated the mechanism by which human prolactin (hPRL) binds the extracellular domain of the human prolactin receptor (hPRLbp) using surface plasmon resonance (SPR) technology. We have covalently coupled hPRL to the SPR chip surface via coupling chemistries that reside in and block either site 1 or site 2. Equilibrium binding experiments using saturating hPRLbp concentrations show that site 2 receptor binding is dependent on site 1 receptor occupancy. In contrast, site 1 binding is independent of site 2 occupancy. Thus, sites 1 and 2 are functionally coupled, site 1 binding inducing the functional organization of site 2. Site 2 of hPRL does not have a measurable binding affinity prior to hPRLbp binding at site 1. After site 1 receptor binding, site 2 affinity is increased to values approaching that of site 1. Corruption of either site 1 or site 2 by mutagenesis is consistent with a functional coupling of sites 1 and 2. Fluorescence resonance energy transfer (FRET) experiments indicate that receptor binding at site 1 induces a conformation change in the hormone. These data support an "induced-fit" model for prolactin receptor binding where binding of the first receptor to hPRL induces a conformation change in the hormone creating the second receptor-binding site.


Subject(s)
Models, Chemical , Prolactin/chemistry , Prolactin/metabolism , Receptors, Prolactin/chemistry , Receptors, Prolactin/metabolism , Binding, Competitive/genetics , Cysteine/genetics , Dextrans/chemistry , Fluorescence Resonance Energy Transfer/methods , Glycine/genetics , Glycine/metabolism , Humans , Kinetics , Methionine/genetics , Methionine/metabolism , Mutagenesis, Site-Directed , Prolactin/genetics , Prolactin/isolation & purification , Protein Binding/genetics , Protein Conformation , Receptors, Prolactin/antagonists & inhibitors , Receptors, Prolactin/isolation & purification , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Spectrophotometry, Ultraviolet , Surface Plasmon Resonance/methods
3.
Mol Cell Endocrinol ; 190(1-2): 51-63, 2002 Apr 25.
Article in English | MEDLINE | ID: mdl-11997178

ABSTRACT

The hormone prolactin (PRL) is the product of a single gene synthesized by pituitary and many extrapituitary tissues. In this study, we have purified and sequenced by mass spectrometry a 29 kDa protein from human synovial liquid, bound to the proteoglycan component of synovial liquid that showed an identical sequence in 20 amino acids to hPRL. We have also found PRL receptor (PRLR) in human knee tissues. The cartilage from osteoarthritic patients shows transcripts of the long PRLR isoform while synovial tissue expresses the intermediate PRLR isoform. Pluripotent mesenchymal stem cells (MSCs) can be isolated from adult bone marrow providing an excellent tool to study MSC-derived differentiation processes. We analyzed the expression of the PRL-PRLR system in hMSCs and during the acquisition of chondrocyte phenotype. We show by RT-PCR that intermediate PRLR isoform is expressed in hMSCs and that PRL exerts a significant increase in cell proliferation. In MSC aggregates cultured in chemically defined medium, we found that extrapituitary PRL transcripts are expressed and the receptor switches isoform expression from the intermediate to long isoform. Furthermore, in cell aggregates, PRL induces type II collagen and extrapituitary PRL expression. Histomorphologic analysis of cell aggregates showed that PRL induces the synthesis of proteoglycans and, in combination with glucocorticoids, a tissue structure with cells organized in longitudinal columns. Under the above conditions, electron microscopic observations show that PRL both downregulates the formation of fibrils of type II collagen and induces cell-cell interactions. All the results presented are consistent with a role of the PRL-PRLR system in bone/cartilage formation/repair processes.


Subject(s)
Knee Joint/physiology , Pluripotent Stem Cells/physiology , Prolactin/physiology , Synovial Fluid/chemistry , Adult , Aged , Aged, 80 and over , Amino Acid Sequence , Bone Marrow Cells/drug effects , Bone Marrow Cells/physiology , Bone Marrow Cells/ultrastructure , Cartilage, Articular/physiology , Cell Aggregation , Cells, Cultured , Chondrogenesis/physiology , Female , Glucocorticoids/pharmacology , Humans , Male , Molecular Sequence Data , Pluripotent Stem Cells/drug effects , Pluripotent Stem Cells/ultrastructure , Prolactin/genetics , Prolactin/isolation & purification , Prolactin/metabolism , Prolactin/pharmacology , Protein Isoforms/genetics , Protein Isoforms/metabolism , Proteoglycans/metabolism , Receptors, Prolactin/genetics , Receptors, Prolactin/isolation & purification , Receptors, Prolactin/metabolism , Transforming Growth Factor beta/pharmacology , Transforming Growth Factor beta3
4.
J Biol Chem ; 276(44): 41086-94, 2001 Nov 02.
Article in English | MEDLINE | ID: mdl-11518703

ABSTRACT

We have identified a novel exon 11 of the human prolactin receptor (hPRLR) gene that is distinct from its rodent counterparts and have demonstrated the presence of two novel short forms of the hPRLR (S1(a) and S1(b)), which are derived from alternative splicing of exons 10 and 11. S1(a) encodes 376 amino acids (aa) that contain partial exon 10 and a unique 39-aa C-terminal region encoded by exon 11. S1(b) encodes 288 aa that lack the entire exon 10 and contains 3 amino acids at the C terminus derived from exon 11 using a shifted reading frame. These short forms, which were found in several normal tissues and in breast cancer cell lines, were expressed as cell surface receptors and possessed binding affinities comparable with the long form. Unlike the long form, neither short form was able to mediate the activation of the beta-casein gene promoter induced by prolactin. Instead they acted as dominant negative forms when co-expressed with the long form in transfected cells. Due to a marked difference in the cellular levels between the two short forms in transfected cells, S1(b) was more effective in inhibiting the prolactin-induced activation of the beta-casein gene promoter mediated by the long form of the receptor. The low cellular level of S1(a) was due to its more rapid turnover than the S1(b) protein. This is attributable to specific residues within the C-terminal unique 39 amino acids of the S1(a) form and may represent a new mechanism by which the hPRLR is modulated at the post-translational level. Since both short forms contain abbreviated cytoplasmic domains with unique C termini, they may also exhibit distinct signaling pathways in addition to modulating the signaling from the long form of the receptor. These receptors may therefore play important roles in the diversified actions of prolactin in human tissues.


Subject(s)
Alternative Splicing , Exons , Receptors, Prolactin/isolation & purification , Amino Acid Sequence , Animals , Base Sequence , COS Cells , Caseins/genetics , DNA, Complementary , Humans , Ligands , Molecular Sequence Data , Prolactin/metabolism , RNA, Messenger/genetics , Receptors, Prolactin/chemistry , Receptors, Prolactin/genetics , Receptors, Prolactin/metabolism , Transfection , Tumor Cells, Cultured
5.
Gen Comp Endocrinol ; 118(2): 302-9, 2000 May.
Article in English | MEDLINE | ID: mdl-10890569

ABSTRACT

The cDNA of the extracellular domain of rainbow trout (Oncorhynchus mykiss) prolactin receptor (trPRLR-ECD) was cloned in the prokaryotic expression vector pMON to enable its expression in Escherichia coli after induction with nalidixic acid. The bacterially expressed trPRLR-ECD protein, contained within the refractile body pellet, was solubilized in 4.5 M urea, refolded, and purified on a Q-Sepharose column, pH 8, by stepwise elution with NaCl. The bioactive monomeric 26-kDa fraction was eluted in 0.2 M NaCl, yielding 20 mg/2.5 L of induced culture. The purified protein was over 98% homogeneous, as shown by SDS-PAGE in the presence or absence of reducing agent and by chromatography on a Superdex column. Binding experiments using [125I]ovine placental lactogen (oPL) as a ligand revealed that human growth hormone (hGH), oPL, and ovine prolactin (oPRL) were the most effective competitors, with respective IC50 values of 1.32, 2.27, and 2.70 nM. Chicken (ch) PRL did not compete at all, and homologous trPRL was much less effective, with a corresponding IC50 value of 1826 nM. Gel-filtration was used to determine the stoichiometry of trPRLR-ECD's interaction with oPL, hGH, and oPRL. Only oPL yielded a 2:1 complex, whereas hGH and oPRL formed only 1:1 complexes, with excess trPRLR-ECD being seen at the initial 2:1 trPRLR-ECD:hGH or trPRLR-ECD:oPRL ratios. No studies were performed with chPRL because of its inability to compete with [125I]oPL or with trPRL because of its low affinity toward trPRLR-ECD. The present results agree with previous findings indicating, as in mammals, that homologous PRL interacts transiently with its receptor and suggest that transient homologous PRL-induced homodimerization of the receptor is sufficient to initiate a biological signal, despite the fact that, in classical binding experiments, only low specific binding can be detected.


Subject(s)
Cloning, Molecular , Oncorhynchus mykiss/genetics , Receptors, Prolactin/genetics , Animals , Binding, Competitive , Chickens , Chromatography, Gel , Escherichia coli/genetics , Gene Expression , Human Growth Hormone/metabolism , Iodine Radioisotopes , Placental Lactogen/metabolism , Prolactin/metabolism , Protein Structure, Tertiary , Receptors, Prolactin/isolation & purification , Receptors, Prolactin/metabolism , Recombinant Proteins , Sheep , Transfection
6.
J Mol Endocrinol ; 19(2): 109-20, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9343303

ABSTRACT

Prolactin is a pituitary hormone that binds to specific receptors in numerous tissues. Depending on the size of their cytoplasmic domain, long and short prolactin receptors (l-PR, s-PR) have been described. Up to now, s-PR were found in rodents only. We report here the cloning of full-length coding sequences for short and long ovine prolactin receptors (s-oPR, l-oPR). The only difference between s- and l-oPR coding sequences was, respectively, the presence or absence of a 39 base pair insert at the beginning of the cytoplasmic domain, with two contiguous inframe stop codons at its 3' end. Sequence comparison revealed that the alternative splicing producing s- and l-oPR was different from that of rodents, although the resulting proteins were very similar. PCR experiments on ovine genomic DNA showed that the 39 base pair insert was directly linked to the downstream exon, and separated from the upstream exon by an 800 base pair intron. Thus, the alternative splicing used a single intron with one 5' and two 3' sites. The same organization was found in bovine and caprine genomes, suggesting that this feature is general in ruminants and different from rodents, which use mutually exclusive exons to produce s-PR and l-PR.


Subject(s)
Alternative Splicing , DNA, Complementary/isolation & purification , Receptors, Prolactin/genetics , Amino Acid Sequence , Animals , Base Sequence , Cattle , Cloning, Molecular , Genome , Goats , Isomerism , Molecular Sequence Data , Rabbits , Rats , Receptors, Prolactin/isolation & purification , Sequence Analysis, DNA , Sheep
7.
Mol Cell Endocrinol ; 115(1): 1-11, 1995 Nov 30.
Article in English | MEDLINE | ID: mdl-8674857

ABSTRACT

Complementary (c)DNA of the extracellular domain of rat prolactin receptor (rPRLR-ECD) was cloned in the prokaryotic expression vector pTrc99A, and expressed in Escherichia coli following induction with isopropyl-b-D-thiogalactopyranoside. The expressed rPRLR-ECD protein, contained within the refractile body pellet was solubilized in 4.5 M urea, refolded and purified on a Q-Sepharose column by stepwise elution with NaCl. Only approximately 10% of the expressed protein refolded as a monomeric fraction, yielding 5-6 mg/l of induced culture. The purified protein was over 98% homogeneous, as shown by SDS-PAGE in the presence or absence of reducing agent, and by chromatography on a Superdex column. Its molecular mass, determined by SDS-PAGE in the absence of reducing agent, was 28 kDa, and by gel filtration, 25.6 kDa. Binding experiments indicated high affinity for bovine placental lactogen (bPL) and human growth hormone (hGH) as compared to ovine (o) or rat PRLs. Gel filtration was used to determine the stoichiometry of rPRLR-ECD's interaction with these hormones. At a 5 microM initial concentration of the hormones, formation of 2:1 (ECD:ligand) complexes was detected with bPL, hGH and oPRL whereas only 1:1 complex was formed with rPRL. Dilution (25-fold) of these complexes did not affect the stoichiometry with bPL, whereas with hGH a clear tendency towards dissociation of the initial 2:1 complex to 1:1 complex was observed. This tendency was even stronger in the case of oPRL. Although all four hormones exhibited nearly identical activities in the Nb2-11C lymphoma cell bioassay, the ability of the purified rat or rabbit PRLR-ECD to inhibit hormonal mitogenic activity generally reflected their affinity for the respective hormones. In view of these and former results, we suggest that unlike in the GH:GHR-ECD interaction, the inability of lactogenic hormones to form a 1:2 complex with soluble recombinant PRLR-ECDs does not necessarily predicts lack of biological activity.


Subject(s)
Receptors, Prolactin/isolation & purification , Animals , Base Sequence , Binding, Competitive , Cattle , Cloning, Molecular , DNA Primers/genetics , DNA, Complementary/genetics , Escherichia coli/genetics , Genetic Vectors , Growth Hormone/metabolism , Humans , In Vitro Techniques , Molecular Sequence Data , Prolactin/metabolism , Rabbits , Rats , Receptors, Prolactin/genetics , Receptors, Prolactin/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Tumor Cells, Cultured
8.
Mol Endocrinol ; 9(11): 1461-7, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8584023

ABSTRACT

The mechanism of action of the pituitary hormone PRL was studied in hepatocytes of lactating rats. PRL receptor immune complexes obtained from liver lysates have an associated tyrosine kinase activity. The tyrosine kinase has been identified in isolated hepatocytes as pp60c-src. Incubation of hepatocytes with PRL induces the association of PRL receptor with pp60c-src and the resultant stimulation of its tyrosine kinase activity. Furthermore, PRL stimulates the gene expression of c-fos, c-jun, and c-src. All of these findings support the idea that the pp60c-src tyrosine kinase participates in the early steps of the PRL intracellular signaling that promotes cell growth in liver cells.


Subject(s)
Liver/metabolism , Proto-Oncogene Proteins pp60(c-src)/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Receptors, Prolactin/metabolism , Signal Transduction/physiology , Animals , Antigen-Antibody Complex/isolation & purification , Cell Division , Female , Gene Expression Regulation , Lactation , Macromolecular Substances , Phosphorylation , Prolactin/pharmacology , Protein Processing, Post-Translational , Proto-Oncogene Proteins c-fos/biosynthesis , Proto-Oncogene Proteins c-fos/genetics , Proto-Oncogene Proteins c-jun/biosynthesis , Proto-Oncogene Proteins c-jun/genetics , Proto-Oncogene Proteins pp60(c-src)/genetics , Proto-Oncogene Proteins pp60(c-src)/isolation & purification , RNA, Messenger/biosynthesis , Rats , Rats, Wistar , Receptor Protein-Tyrosine Kinases/isolation & purification , Receptors, Prolactin/immunology , Receptors, Prolactin/isolation & purification
9.
Arch Biochem Biophys ; 322(2): 506-15, 1995 Oct 01.
Article in English | MEDLINE | ID: mdl-7574727

ABSTRACT

Previously we demonstrated that lactogen-dependent Nb2 cells express a nuclear prolactin (PRL) receptor. Thus, the nuclear receptor expressed in PRL-dependent Nb2-11 and -independent Nb2-SFJCD1 cells was characterized. Initially, the potential proteolytic processing of internalized 125I-rPRL was investigated. Radiolabeled hormone eluted from a Sephadex G-100 column with a retention time identical to that found for stock hormone, indicating that nuclear PRL was intact. Experiments to investigate the nuclear distribution of the hormone demonstrated that 90% of 125I-rPRL bound to chromatin; the remaining was distributed between "sap-protein" and nucleoplasmic fractions. Chromatin-bound PRL was resistant to high salt and detergent extraction indicating a tight association. Immunoprecipitation and immunoblot analysis revealed the PRL receptor to be 62 kDa in each cell line. Affinity crosslinking experiments and immunoprecipitation demonstrated that 125I-rPRL complexed with a protein(s) of similar M(r) in intact cells. 125I-rPRL binding was saturable and of high affinity (Kds of 180 and 170 pM, for Nb2-11 and Nb2-SFJCD1 lines, respectively). PRL binding was competitively inhibited by ovine and bovine PRLs and hGH, but not by rat GH, and by monoclonal antibodies (McAbs) which recognize the lactogen binding site. These results demonstrate that: (1) 125I-rPRL translocates intact to the Nb2 cell nucleus and tightly associates with chromatin; (2) the chromatin receptor specifically binds 125I-rPRL with high affinity; and (3) the chromatin receptor is essentially identical to its membrane counterpart with respect to mass, binding characteristics, and McAb recognition.


Subject(s)
Cell Nucleus/metabolism , Nuclear Proteins/metabolism , Prolactin/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Receptors, Prolactin/metabolism , Animals , Binding, Competitive , Biological Transport , Cell Compartmentation , Cell Fractionation , Chromatin/chemistry , Chromatin/metabolism , Chromatography, Gel , Cross-Linking Reagents , Immunoblotting , Lymphoma/metabolism , Nuclear Proteins/isolation & purification , Precipitin Tests , Protein Binding , Rats , Receptors, Cytoplasmic and Nuclear/isolation & purification , Receptors, Peptide/metabolism , Receptors, Prolactin/isolation & purification , Tumor Cells, Cultured
10.
J Endocrinol ; 144(3): 393-403, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7738463

ABSTRACT

The cDNA of the extracellular domain of bovine prolactin receptor (bPRLR-ECD) was cloned and expressed at high yield as an insoluble protein in Escherichia coli. This protein was solubilized, refolded and purified to > 98% homogeneity yielding 80 mg of monomeric fraction per 2 litres of induced culture. Its molecular mass was 25.7 kDa, as determined by SDS-PAGE in the absence of reducing agent and 24 kDa by gel filtration on a Superdex column. Binding experiments revealed that bPRLR-ECD binds to human (h) GH (hGH) with high affinity, whereas its affinity for ovine (o) or bovine (b) prolactins (PRLs) was lower and for bovine placental lactogen (bPL) very low. The affinity of bPRLR-ECD for the latter three hormones was, however, much higher than that of membrane-embedded or solubilized bPRLR. The stoichiometries of interaction of bPRLR-ECD with hGH, oPRL, bPRL and bPL were determined by gel-filtration chromatography. Even at a 3:1 ECD excess, only 1:1 complexes were detected at microM concentrations of ECD and ligand. At an up to 32-fold dilution, the complexes with oPRL, bPRL, and particularly bPL, underwent progressive dissociation, whereas the complex with hGH remained stable. Although all four hormones exhibited nearly identical activity in the Nb2 lymphoma cell bioassay, the ability of bPRLR-ECD to inhibit hormonal mitogenic activities differed, generally reflecting its affinity for the respective hormones. In view of these and previous results, we suggest that, unlike in the GH:GHR-ECD interaction, neither the stoichiometry of interaction of bovine or other PRLR-ECDs nor the affinity constants can predict the biological potency of the different lactogenic hormones.


Subject(s)
Prolactin/metabolism , Receptors, Prolactin/isolation & purification , Animals , Base Sequence , Cattle , Chromatography, Gel , DNA Primers , Electrophoresis, Polyacrylamide Gel , Escherichia coli , Female , Growth Hormone/metabolism , Humans , Molecular Sequence Data , Placental Lactogen/metabolism , Rats , Receptors, Prolactin/genetics , Receptors, Prolactin/metabolism , Recombinant Proteins/isolation & purification , Sequence Homology, Amino Acid , Sheep , Species Specificity
11.
J Biol Chem ; 270(10): 5136-43, 1995 Mar 10.
Article in English | MEDLINE | ID: mdl-7534288

ABSTRACT

We report the first in vivo study demonstrating tyrosine phosphorylation of mammary gland proteins including the prolactin receptor, in response to the injection of prolactin. Immunoblotting of mammary gland membrane extracts revealed that subunits of 200, 130, 115, 100, 90, 70, and 45 kDa display increased tyrosine phosphorylation within 5 min of prolactin administration. The 100-kDa component was identified as the full-length prolactin receptor by a variety of means including immunoprecipitation and immunoblotting with monoclonal (U5, 917, 110, and 82) and polyclonal (46) antibodies to the prolactin receptor. Maximal receptor phosphorylation was seen within 1 min of hormone injection, and to obtain a strong response it was necessary to deprive rabbits of their endogenous prolactin for 36 h. Rapid tyrosine phosphorylation of the full-length receptor was verified by its demonstration in Chinese hamster ovary cells stably transfected with rabbit prolactin receptor cDNA. Both in vivo and in vitro, the phosphorylation signal was transient, being markedly reduced within 10 min of exposure to prolactin. Tyrosine-phosphorylated receptor was shown to be associated with JAK 2 by immunoblotting of receptor immunoprecipitated from transfected Chinese hamster ovary cells with polyclonal 46. A 48-kDa ATP-binding protein was also shown to be associated with the mammary gland receptor by U5 or polyclonal 46 immunoprecipitation of receptor complexes following covalent labeling with [alpha-32P]azido-ATP. Our demonstration of prolactin receptor tyrosine phosphorylation raises the possibility of signaling pathways regulated by receptor/SH2 protein interaction, which would facilitate prolactin specific responses. The fact that a period of hormone deprivation is needed for significant hormone triggered receptor phosphorylation indicates that the mammary gland receptor exists in a largely desensitized state in vivo, analogous to the related growth hormone receptor.


Subject(s)
Mammary Glands, Animal/metabolism , Prolactin/pharmacology , Proto-Oncogene Proteins , Receptors, Prolactin/metabolism , Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/metabolism , Animals , Antibodies , Antibodies, Monoclonal , Azides/metabolism , Blotting, Western , CHO Cells , Cricetinae , Female , Janus Kinase 2 , Lactation , Macromolecular Substances , Phosphorus Radioisotopes , Phosphorylation , Phosphotyrosine , Protein-Tyrosine Kinases/isolation & purification , Protein-Tyrosine Kinases/metabolism , Rabbits/immunology , Receptors, Prolactin/chemistry , Receptors, Prolactin/isolation & purification , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Transfection , Tyrosine/analogs & derivatives , Tyrosine/metabolism
12.
J Endocrinol ; 144(1): 143-51, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7891016

ABSTRACT

Although prolactin (PRL) receptors are found in many mammalian tissues, specific PRL binding to mammalian skin has not been demonstrated. In view of the temporal relationships observed between photoperiod, circulating PRL and pelage replacement in seasonally responsive mammals, we sought to provide evidence of PRL receptors in ovine skin. Cryosections of skin from New Zealand Wiltshire ewes were incubated with radiolabelled human GH (125I-hGH) and ovine PRL (125I-oPRL) in the presence and absence of excess unlabelled hormones (hGH, oPRL or ovine GH (oGH)). Binding was inhibited by unlabelled oPRL and hGH but not by oGH. In microautoradiographs, both radioligands were localised most strongly in the dermal papillae of wool follicles in the anagen (growth) phase of the hair cycle and in apocrine sweat glands. Higher levels of specific binding to dermal papilla cells, compared with the follicle epithelial matrix and the surrounding dermis, were confirmed by measurement of microautoradiograph silver grain density (respectively, 34.1 +/- 3.0, 11.4 +/- 1.0 and 5.5 +/- 0.5 grains per 100 microns2 (mean +/- S.E.M., n = 10)). Total binding for 125I-hGH and 125I-oPRL radioligands to follicle dermal papilla was not significantly different (34.1 +/- 3.0 vs 43.6 +/- 2.5 grains per 100 microns2, n = 10) but the level of non-specific binding of 123I-oPRL was higher than for 125I-hGH (18.9 +/- 1.4 vs 6.1 +/- 0.6 grains per 100 microns2, n = 10; P < 0.001). Binding assays of receptors in crude microsomal membranes extracted from ovine skin were used to ascertain binding capacity and specificity.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Receptors, Prolactin/isolation & purification , Sheep/metabolism , Skin/chemistry , Wool , Animals , Autoradiography , Female , Growth Hormone/metabolism , Humans , Protein Binding , Radioligand Assay , Receptors, Prolactin/metabolism , Sensitivity and Specificity , Sweat Glands/chemistry
13.
Cell Mol Biol (Noisy-le-grand) ; 40(3): 359-71, 1994 May.
Article in English | MEDLINE | ID: mdl-7920180

ABSTRACT

To investigate whether glycanic chains of prolactin receptors (PRL-R) play a role in hormone binding activity, comparison was made of rat and mouse liver solubilized receptors with respect to both their affinity for the hormone and their glycosylation properties. As compared with rat receptors, mouse receptors exhibited a 2-fold higher affinity for human growth hormone (hGH), the hormone being bound by both tissues with a lactogenic specificity. Along with this increased affinity, mouse receptors had a 2 lower M(r) relative to rat receptors (62 kDa versus 64 kDa as measured on hGH cross-linked receptors). These differences could be ascribed to different glycosylation properties of the receptors from the two species, as supported by the followings. 1) After treatment with endoglycosidase F (endo F), rat and mouse PRL-R no longer exhibited any difference in their M(r) (54 kDa for both cross-linked receptors). 2) Neuraminidase treatment increased by 37% the binding of hGH to mouse receptors, but was ineffective on the hormone-binding to rat receptors. Conversely, wheat germ agglutinin (WGA), another sialic acid specific probe, decreased hGH binding to rat receptors by 25%, but had no effect on this process for mouse ones. 3) Marked differences were observed in the recoveries of rat and mouse hormone-receptor (HR) complexes from ricin-1- (RCA1-), concanavalin A- (ConA-) and WGA-immobilized lectins. These differences were reduced (RCA1 and ConA) or abolished (WGA) after rat and mouse receptor desialylation by neuraminidase, a treatment which decreased the M(r) of both receptors by 2 kDa. Taken together, these results strongly suggest that the PRL-R from rat and mouse liver contain biantennary N-linked oligosaccharidic chains with distinct type of sialylation, which may account for their differential hormone-binding affinities.


Subject(s)
Liver/chemistry , Mice/metabolism , Rats/metabolism , Receptors, Prolactin/metabolism , Receptors, Somatotropin/metabolism , Animals , Chromatography, Affinity , Female , Glycosylation/drug effects , Growth Hormone/metabolism , Lectins/metabolism , Molecular Weight , N-Acetylneuraminic Acid , Neuraminidase/pharmacology , Prolactin/metabolism , Protein Binding/drug effects , Rats, Wistar , Receptors, Prolactin/classification , Receptors, Prolactin/drug effects , Receptors, Prolactin/isolation & purification , Receptors, Somatotropin/classification , Receptors, Somatotropin/drug effects , Receptors, Somatotropin/isolation & purification , Sialic Acids/metabolism , Species Specificity , Wheat Germ Agglutinins/pharmacology
14.
J Biol Chem ; 269(5): 3318-24, 1994 Feb 04.
Article in English | MEDLINE | ID: mdl-8106371

ABSTRACT

The cDNA of the extracellular domain of the rabbit prolactin receptor (rbPRLR-ECD) was cloned in the prokaryotic expression vector pTrc99A to enable its expression in Escherichia coli after induction with isopropyl-1-thio-beta-D-galactopyranoside. The bacterially expressed rbPRLR-ECD protein, contained within the refractile body pellet, was solubilized in 4.5 M urea, refolded, and purified on a Q-Sepharose column by stepwise elution with NaCl. The bioactive monomeric fraction was eluted in 0.05 M NaCl, yielding 15-20 mg/8 liters of induced culture. The purified protein was > 98% homogeneous, as shown by SDS-polyacrylamide gel electrophoresis in the presence or absence of reducing agent and by chromatography on a Superdex column. Its molecular mass was 25 kDa as determined by SDS-polyacrylamide gel electrophoresis in the absence of reducing agent and 22 kDa as determined by gel filtration. Binding experiments revealed remarkable differences between rabbit and porcine prolactins (PRLs) and the other tested lactogenic hormones. Gel filtration was used to determine the stoichiometry of the rbPRLR-ECD interaction with ovine, rabbit, and porcine PRLs, with human growth hormone and its truncated des-7 analogue, and with bovine placental lactogen (bPL) and des-13-bPL. The formation of only 1:1 complexes was indicated, except with bPL, for which a 2:1 complex was detected. Identical stoichiometry was also obtained using excess radiolabeled rbPRLR-ECD in gel filtration experiments. Interaction of 125I-labeled ovine PRL with rbPRLR-ECD secreted into conditioned medium by rbPRLR-ECD cDNA-transfected COS 7 cells also indicated formation of 1:1 molar complexes. Despite the differences in binding potency and stoichiometries of the interaction with rbPRLR-ECD, all seven tested hormones were biologically active in inducing PRL receptor-mediated casein synthesis in explants of rabbit mammary gland. We therefore propose that the formation of the 1:2 complexes with soluble rbPRLR-ECD is not predictive of biological activity of the different lactogenic hormones.


Subject(s)
Peptide Fragments/metabolism , Prolactin/metabolism , Receptors, Prolactin/metabolism , Amino Acid Sequence , Animals , Base Sequence , Binding Sites , Binding, Competitive , Caseins/biosynthesis , Chromatography, Gel , Cloning, Molecular , Culture Media, Conditioned , DNA Primers , Electrophoresis, Polyacrylamide Gel , Escherichia coli , Female , Gene Expression , Growth Hormone/metabolism , Humans , Kinetics , Mammary Glands, Animal/drug effects , Mammary Glands, Animal/metabolism , Molecular Sequence Data , Molecular Weight , Organ Culture Techniques , Peptide Fragments/isolation & purification , Polymerase Chain Reaction , Prolactin/pharmacology , Protein Folding , Pseudopregnancy , Rabbits , Receptors, Prolactin/biosynthesis , Receptors, Prolactin/isolation & purification , Recombinant Proteins/biosynthesis , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Swine , Transfection
15.
J Biol Chem ; 269(7): 5364-8, 1994 Feb 18.
Article in English | MEDLINE | ID: mdl-7508935

ABSTRACT

JAK family tyrosine kinases have recently been implicated in intracellular signal transduction by transmembrane cytokine receptors of the interferon (IFN) and hematopoietin receptor families. Using the prolactin (PRL)-dependent rat pre-T cell line Nb2, a PRL receptor-associated, candidate tyrosine kinase of 120-130 kDa was recently characterized (1). In the present work this protein is identified as JAK2, based upon reciprocal anti-JAK2 and anti-phosphotyrosine immunoprecipitation and immunoblotting. JAK2 underwent rapid and transient tyrosine phosphorylation in response to receptor activation, reaching peak levels within 5 min of exposure to 100 nM PRL at 37 degrees C. In vitro tyrosine kinase assays using either [gamma-32P]ATP and autoradiography or unlabeled ATP combined with anti-phosphotyrosine immunoblotting, demonstrated that the activity of JAK2 was stimulated by PRL. Phosphoamino acid analysis of JAK2 after in vitro tyrosine kinase assay revealed that the majority of phosphate was incorporated into tyrosine residues. Furthermore, JAK2 was associated with PRL receptors to a comparable extent before and after PRL binding, as demonstrated by anti-receptor immunoprecipitation and subsequent anti-JAK2 immunoblotting. We propose that binding of ligand to the PRL receptor activates preassociated JAK2, and that this enzyme generates the initial signal in the intracellular communication cascade.


Subject(s)
Prolactin/pharmacology , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins , Receptor Protein-Tyrosine Kinases/metabolism , Receptors, Prolactin/metabolism , Adenosine Triphosphate/metabolism , Animals , Autoradiography , Cell Line , Enzyme Activation , Immunoblotting , Janus Kinase 2 , Membrane Proteins/isolation & purification , Membrane Proteins/metabolism , Phosphorus Radioisotopes , Phosphorylation , Phosphotyrosine , Protein-Tyrosine Kinases/drug effects , Rats , Receptors, Prolactin/isolation & purification , Sheep , T-Lymphocytes , Tyrosine/analogs & derivatives , Tyrosine/analysis , Tyrosine/metabolism
16.
Mol Cell Endocrinol ; 98(1): 1-8, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8143909

ABSTRACT

The antilactogen binding site (ALBS) is a membrane associated protein to which tamoxifen (TAM) and related non-steroidal antiestrogens, but not estrogen, bind. It is through this site that TAM inhibits lactogen binding to the prolactin (Prl) receptor and subsequent Prl induced growth and differentiation in target tissues. Binding of lactogens to the Prl receptor is inhibited by TAM or 4-hydroxy-TAM at 4 degrees C as well as room temperature, thus suggesting that the ALBS is not an enzyme. TAM acts by inhibiting the binding of lactogens to the receptor rather than promoting dissociation of the hormone-receptor complex. Lactogens bind to mammary gland membranes with an Kd of 4.3-8.2 x 10(-10) M. In the presence of 10(-7) M TAM the affinity decreased to a Kd of 0.8-1.6 x 10(-9) M. Binding of 3H-TAM to mammary gland membranes was effectively inhibited by an anti-Prl receptor antibody, thus suggesting a close relationship between the Prl receptor and the ALBS. Separate affinity purification of the ALBS and the Prl receptor resulted in peak fractions demonstrating specific binding activity for both TAM and lactogenic hormones. Re-isolation of the affinity purified Prl receptor on a TAM-Sepharose affinity resin again resulted in co-elution of both binding activities. The isolates from both affinity resins contained primarily a single band with an apparent molecular mass of 90 kDa. This band was precipitated with the anti-Prl receptor antibody and specifically bound the affinity label ring-3H-TAM aziridine.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Membrane Proteins/metabolism , Tamoxifen/metabolism , Animals , Cholic Acids/pharmacology , Chromatography, Affinity , Female , Kinetics , Lactation , Liver/metabolism , Mammary Glands, Animal/metabolism , Membrane Proteins/isolation & purification , Mice , Mice, Inbred C3H , Prolactin/metabolism , Protein Binding , Receptors, Drug/isolation & purification , Receptors, Drug/metabolism , Receptors, Prolactin/isolation & purification , Receptors, Prolactin/metabolism , Tamoxifen/analogs & derivatives
17.
J Endocrinol ; 139(1): 37-49, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8254292

ABSTRACT

Developmental variation in the expression of the prolactin receptor in the ruminant mammary gland was investigated. Affinity chromatography revealed that bovine prolactin and human GH each bound to the same mammary gland proteins, yielding fractions enriched in binding activity and a protein of M(r) 36,000, assumed to be a bovine prolactin receptor. Affinity cross-linking of 125I-labelled human GH to mammary microsomes confirmed that the M(r) 36,000 protein was a bovine prolactin receptor. Binding assays of receptors in microsomes from the mammary tissue of cows and ewes at various stages of the lactational/reproductive cycle indicated developmental regulation of receptor concentration, but not receptor type, as no other bovine prolactin receptor type was detected by affinity cross-linking. These results suggest that differences in the response to prolactin in the mammary gland at various developmental stages in ruminants are not due to the expression of different forms of the prolactin receptor, and the lack of a prolactin effect on established lactation in ruminants is not due to the absence of the M(r) 36,000 form of the prolactin receptor.


Subject(s)
Cattle/metabolism , Lactation/metabolism , Mammary Glands, Animal/metabolism , Pregnancy, Animal/metabolism , Receptors, Prolactin/isolation & purification , Animals , Chromatography, Affinity , Female , Mice , Mice, Inbred BALB C , Microsomes/metabolism , Molecular Weight , Pregnancy , Rats , Rats, Sprague-Dawley , Receptors, Prolactin/metabolism , Sheep
18.
J Biol Chem ; 268(30): 22347-52, 1993 Oct 25.
Article in English | MEDLINE | ID: mdl-8226744

ABSTRACT

A clone of the extracellular domain of the rat liver prolactin receptor was generated by the RNA-based polymerase chain reaction, and the NH2-terminal 210 amino acids were expressed in HeLa cells using a vaccinia virus/T7 hybrid expression system. The protein was isolated from serum-free culture medium directly by chromatography on an ovine prolactin affinity column and yielded approximately 1.5 mg of protein/liter of suspension culture. The extracellular domain of the rat prolactin receptor inhibited the ovine prolactin-dependent mitogenesis of rat lymphoma Nb2 cells with an IC50 of 7.1 pM and bound 125I-labeled ovine prolactin with a Kd of 1.21 +/- 0.19 nM. In contrast, the binding of the 125I-labeled extracellular domain to ovine prolactin exhibited positive cooperativity with a Hill coefficient of 1.73. High pressure gel filtration chromatography was used to demonstrate the formation of a complex consisting of one molecule of ovine prolactin and two molecules of the extracellular domain of the rat prolactin receptor. Complex formation occurred with human growth hormone, but not with ovine growth hormone, a non-lactogen.


Subject(s)
Liver/metabolism , Prolactin/metabolism , Receptors, Prolactin/metabolism , Animals , Base Sequence , Cell Line , Cell Membrane/metabolism , Chlorocebus aethiops , Chromatography, Gel , Chromatography, High Pressure Liquid , Cloning, Molecular , DNA Primers , Female , Kidney , Kinetics , Lymphoma , Molecular Sequence Data , Polymerase Chain Reaction , Pregnancy , Prolactin/isolation & purification , Promoter Regions, Genetic , Rats , Rats, Sprague-Dawley , Receptors, Prolactin/biosynthesis , Receptors, Prolactin/isolation & purification , Restriction Mapping , Sheep , Transfection , Tumor Cells, Cultured
19.
J Biol Chem ; 267(33): 24076-81, 1992 Nov 25.
Article in English | MEDLINE | ID: mdl-1385436

ABSTRACT

The mechanism of action of prolactin (PRL) has remained obscure despite the unveiling of the primary structure of PRL receptors. The present study demonstrates rapid PRL receptor-mediated tyrosine phosphorylation of at least three cellular proteins, designated p120, p97, and p40, in a rat T-lymphoma (Nb2-11C) as revealed by antiphosphotyrosine immunoblotting. One of the phosphotyrosyl proteins, p120, co-purified with activated PRL receptor complexes obtained using either anti-ligand or anti-receptor antibodies. Furthermore, in vitro incubation of affinity-purified PRL receptor complexes from PRL-stimulated cells with ATP in the presence of a tyrosine phosphatase inhibitor, resulted in a 10-15-fold increase in the phosphotyrosine content of p120, as revealed by antiphosphotyrosine immunoblotting. Parallel experiments utilizing [gamma-32P]ATP confirmed a rapid and time-dependent incorporation of phosphate into p120 in the same affinity-purified PRL receptor complexes. These data provide strong evidence for the involvement of a tyrosine kinase in PRL signal transduction and suggest the presence of a tyrosine kinase within the activated PRL receptor complex.


Subject(s)
Phosphoproteins/metabolism , Prolactin/pharmacology , Protein-Tyrosine Kinases/metabolism , Receptors, Prolactin/metabolism , Adenosine Triphosphate/metabolism , Animals , Autoradiography , Cell Line , Electrophoresis, Polyacrylamide Gel , Enzyme Activation , Humans , Immunoblotting , Kinetics , Membrane Proteins/isolation & purification , Membrane Proteins/metabolism , Molecular Weight , Phosphoproteins/isolation & purification , Phosphorus Radioisotopes , Phosphotyrosine , Receptors, Prolactin/isolation & purification , Tyrosine/analogs & derivatives , Tyrosine/analysis
20.
Proc Natl Acad Sci U S A ; 88(3): 824-8, 1991 Feb 01.
Article in English | MEDLINE | ID: mdl-1992473

ABSTRACT

The biological activities of long and short forms of the prolactin receptor have been compared. These two receptors expressed in mammalian cells were shown to bind prolactin with equal high affinity. The ability of these different forms to transduce the hormonal message was estimated by their capacity to stimulate transcription by using the promoter of a milk protein gene fused to the chloramphenicol acetyltransferase (CAT) coding sequence. Experiments were performed in serum-free conditions to avoid the effect of lactogenic factors present in serum. An approximately 17-fold induction of CAT activity was obtained in the presence of prolactin when the long form of the prolactin receptor was expressed, whereas no induction was observed when the short form was expressed. The present results clearly establish that only the long form of the prolactin receptor is involved in milk protein gene transcription.


Subject(s)
Lactoglobulins/genetics , Milk Proteins/genetics , Prolactin/pharmacology , Receptors, Prolactin/physiology , Transcription, Genetic/drug effects , Animals , Cell Line , Chloramphenicol O-Acetyltransferase/genetics , Chloramphenicol O-Acetyltransferase/metabolism , DNA/genetics , Genetic Vectors , Kinetics , Milk Proteins/biosynthesis , Promoter Regions, Genetic , Rabbits , Receptors, Prolactin/genetics , Receptors, Prolactin/isolation & purification , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/metabolism , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...